Literature DB >> 15464914

Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.

John M Timmerman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15464914     DOI： 10.1016/S1054-3589(04)51012-8

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  3 in total

1.  Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines.

Authors:  Kamran Kafi; David J Betting; Reiko E Yamada; Michael Bacica; Kristopher K Steward; John M Timmerman
Journal:  Mol Immunol       Date:  2008-11-28       Impact factor: 4.407

2.  Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.

Authors:  John M Timmerman; Julie M Vose; Debra K Czerwinski; Wen-Kai Weng; Diane Ingolia; Martha Mayo; Dan W Denney; Ronald Levy
Journal:  Leuk Lymphoma       Date:  2009-01

3.  Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells.

Authors:  David J Betting; Xi Y Mu; Kamran Kafi; Desmond McDonnel; Francisco Rosas; Daniel P Gold; John M Timmerman
Journal:  Vaccine       Date:  2008-11-08       Impact factor: 3.641
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.